These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 21765445)
1. Rosiglitazone protects neuroblastoma cells against advanced glycation end products-induced injury. Wang L; Yu CJ; Liu W; Cheng LY; Zhang YN Acta Pharmacol Sin; 2011 Aug; 32(8):991-8. PubMed ID: 21765445 [TBL] [Abstract][Full Text] [Related]
2. Diosmetin Targeted at Peroxisome Proliferator-Activated Receptor Gamma Alleviates Advanced Glycation End Products Induced Neuronal Injury. Lai MC; Liu WY; Liou SS; Liu IM Nutrients; 2022 May; 14(11):. PubMed ID: 35684047 [TBL] [Abstract][Full Text] [Related]
3. The Citrus Flavonoid Hesperetin Encounters Diabetes-Mediated Alzheimer-Type Neuropathologic Changes through Relieving Advanced Glycation End-Products Inducing Endoplasmic Reticulum Stress. Lai MC; Liu WY; Liou SS; Liu IM Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215394 [TBL] [Abstract][Full Text] [Related]
4. The neuroprotective role of rosiglitazone in advanced glycation end product treated human neural stem cells is PPARgamma-dependent. Chiang MC; Cheng YC; Nicol CJ; Lin CH Int J Biochem Cell Biol; 2017 Nov; 92():121-133. PubMed ID: 28964868 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of (-)-epigallocatechin gallate against advanced glycation endproducts-induced injury in neuronal cells. Lee SJ; Lee KW Biol Pharm Bull; 2007 Aug; 30(8):1369-73. PubMed ID: 17666787 [TBL] [Abstract][Full Text] [Related]
6. Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells. Cellai I; Benvenuti S; Luciani P; Galli A; Ceni E; Simi L; Baglioni S; Muratori M; Ottanelli B; Serio M; Thiele CJ; Peri A Br J Cancer; 2006 Oct; 95(7):879-88. PubMed ID: 16969347 [TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production. Jung TW; Lee JY; Shim WS; Kang ES; Kim SK; Ahn CW; Lee HC; Cha BS J Neurol Sci; 2007 Feb; 253(1-2):53-60. PubMed ID: 17266988 [TBL] [Abstract][Full Text] [Related]
8. Protective role of activating PPARγ in advanced glycation end products-induced impairment of coronary artery vasodilation via inhibiting p38 phosphorylation and reactive oxygen species production. Hua B; Liu Q; Gao S; Li W; Li H Biomed Pharmacother; 2022 Mar; 147():112641. PubMed ID: 35051861 [TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3. Magenta G; Borenstein X; Rolando R; Jasnis MA BMC Cancer; 2008 Feb; 8():47. PubMed ID: 18261208 [TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products. Liang C; Ren Y; Tan H; He Z; Jiang Q; Wu J; Zhen Y; Fan M; Wu Z Br J Pharmacol; 2009 Dec; 158(8):1865-73. PubMed ID: 19917066 [TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis. Fuenzalida K; Quintanilla R; Ramos P; Piderit D; Fuentealba RA; Martinez G; Inestrosa NC; Bronfman M J Biol Chem; 2007 Dec; 282(51):37006-15. PubMed ID: 17965419 [TBL] [Abstract][Full Text] [Related]
12. An Extract from Shrimp Processing By-Products Protects SH-SY5Y Cells from Neurotoxicity Induced by Aβ Zhang Y; Jiao G; Song C; Gu S; Brown RE; Zhang J; Zhang P; Gagnon J; Locke S; Stefanova R; Pelletier C; Zhang Y; Lu H Mar Drugs; 2017 Mar; 15(3):. PubMed ID: 28327516 [TBL] [Abstract][Full Text] [Related]
13. Oroxylum indicum (L.) extract protects human neuroblastoma SH‑SY5Y cells against β‑amyloid‑induced cell injury. Mairuae N; Connor JR; Buranrat B; Lee SY Mol Med Rep; 2019 Aug; 20(2):1933-1942. PubMed ID: 31257498 [TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone activation of PPARγ-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta-induced mitochondrial dysfunction and oxidative stress. Chiang MC; Nicol CJ; Cheng YC; Lin KH; Yen CH; Lin CH Neurobiol Aging; 2016 Apr; 40():181-190. PubMed ID: 26973118 [TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone inhibits chlorpyrifos-induced apoptosis via modulation of the oxidative stress and inflammatory response in SH-SY5Y cells. Lee JE; Park JH; Jang SJ; Koh HC Toxicol Appl Pharmacol; 2014 Jul; 278(2):159-71. PubMed ID: 24793810 [TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone protects human neuroblastoma SH-SY5Y cells against acetaldehyde-induced cytotoxicity. Jung TW; Lee JY; Shim WS; Kang ES; Kim SK; Ahn CW; Lee HC; Cha BS Biochem Biophys Res Commun; 2006 Feb; 340(1):221-7. PubMed ID: 16360119 [TBL] [Abstract][Full Text] [Related]
17. PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms. Yi JH; Park SW; Brooks N; Lang BT; Vemuganti R Brain Res; 2008 Dec; 1244():164-72. PubMed ID: 18948087 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells. Zhang L; Yu H; Zhao X; Lin X; Tan C; Cao G; Wang Z Neurochem Int; 2010 Nov; 57(5):547-55. PubMed ID: 20615444 [TBL] [Abstract][Full Text] [Related]
19. PPAR-γ activation attenuates deltamethrin-induced apoptosis by regulating cytosolic PINK1 and inhibiting mitochondrial dysfunction. Ko J; Park JH; Park YS; Koh HC Toxicol Lett; 2016 Oct; 260():8-17. PubMed ID: 27553674 [TBL] [Abstract][Full Text] [Related]
20. Effect of rosiglitazone on amyloid precursor protein processing and Aβ clearance in streptozotocin-induced rat model of Alzheimer's disease. Wang L; Liu W; Fan Y; Liu T; Yu C Iran J Basic Med Sci; 2017 May; 20(5):474-480. PubMed ID: 28656081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]